Blood Pressure Drug Needs New Cautions, Expert Panel Says
Saturday, November 29th, 2008May 24, 2001 (Bethesda, Md.) — The FDA needs to communicate to doctors that there may be safety questions with the popular Pfizer blood pressure drug Cardura, according to recommendations Thursday from an expert committee to the agency.
But the panel wasn’t sure yet how updated labels for the dr…
